Nicola Pozzi

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome

Posted on November 12, 2020

Maria Orietta Borghi, […], Nicola Pozzi and Pier Luigi Meroni. Frontiers in Immunology, Volume 11, 15 October 2020, Article number 584241 Read More

The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome

Posted on August 14, 2020

Eliza Ruben, William Planer, Mathivanan Chinnaraj, Zhiwei Chen, Xiaobing Zuo, Vittorio Pengo, Vincenzo De Filippis, Ravi K. Alluri, Keith R. McCrae, Paolo Macor, Francesco Tedesco and Nicola Pozzi. The Journal of Biological Chemistry. Volume 295, Issue 31, 31 July 2020, Pages 10794-10806 Read More

VE-1902—A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis

Posted on April 30, 2020

Author links open overlay panelMohanramSivaraja, […], Nicola Pozzi, Enrico Di Cera, C. Michael Gibson, Keith A.A. Fox, David B. Kit.Thrombosis Research, Volume 190, June 2020, Pages 112-121 Read More

Endocrine disruption of androgenic activity by perfluoroalkyl substances: Clinical and experimental evidence

Posted on April 25, 2019

Andrea Di Nisio, Iva Sabovic, Umberto Valente, Simone Tescari, Maria Santa Rocca, Diego Guidolin, Stefano Dall’Acqua, Laura Acquasaliente, Nicola Pozzi, Mario Plebani, Andrea Garolla, Carlo Foresta. Journal of Clinical Endocrinology and Metabolism, Volume 104, Issue 4, 1 April 2019, Pages 1259-1271 Read More

Enhancing the anticoagulant profile of meizothrombin

Posted on January 31, 2019

Bosko M. Stojanovski, Leslie A. Pelc, Xiaobing Zuo, Nicola Pozzi, Enrico Di Cera. Biomolecular Concepts, Volume 9, Issue 1, 2018, Pages 169-175 Read More